E2F1 promotes cancer cell sensitivity to cisplatin by regulating the cellular DNA damage response through miR-26b in esophageal squamous cell carcinoma
In conclusion, our results indicate that E2F1 promotes the chemosensitization to cisplatin in ESCC. The effect may be due to the upregulation of miR-26b because cisplatin-induced cycle arrest depends on miR-26b, which may also disturb the DNA damage response by reducing the expression of ATM and Rb.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Kun Zhang, Bo Zhang, Yun Bai, Limeng Dai Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Genetics | Skin Cancer | Squamous Cell Carcinoma | Study